Businesses of all types can learn a lot from what pharma companies do when their blockbuster drugs come off patent. Some fall off the revenue cliff, and some — like Viagra — do a remarkable job of holding share. In this episode, the team highlights what any business that faces low-priced competition can learn from Viagra’s continued success.